An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans

This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of histochemistry and cytochemistry 2002-03, Vol.50 (3), p.365-383
Hauptverfasser: Brelje, T. Clark, Svensson, Annika M, Stout, Laurence E, Bhagroo, Nicholas V, Sorenson, Robert L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 383
container_issue 3
container_start_page 365
container_title The journal of histochemistry and cytochemistry
container_volume 50
creator Brelje, T. Clark
Svensson, Annika M
Stout, Laurence E
Bhagroo, Nicholas V
Sorenson, Robert L
description This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.
doi_str_mv 10.1177/002215540205000308
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71456005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_002215540205000308</sage_id><sourcerecordid>71456005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</originalsourceid><addsrcrecordid>eNp9kM2O0zAUhS0EYjoDL8ACeQO70OvEjtNlNAKmUMRIlLXlOHbjUWIX2yGaN-CxcWklFkis7o--c67uQegVgXeEcL4GKEvCGIUSGABU0DxBq7wgBQNKn6LVCShOxBW6jvEBgFDKmufoipAmI9VmhX61Dm-naXZ-sDF5NejJKjni9ngMXqoBJ4-_eGeTDzgNGt8HP0qVrCus62ele9zm6adM1jvszR_mU_u5XH_bt3uG72UaFvmIrcutU0FnUOFtHHWKJ3wn3UGHQbr4Aj0zcoz65aXeoO8f3u9v74rd14_b23ZXKMo3qZBcQWcUcN41siFS0dqYjjFlqGl435VlpbUxzChV9pTphgPXVNUgVb3ZgKpu0Nuzb_7vx6xjEpONSo-jdNrPUXBCWQ3AMlieQRV8jEEbcQx2kuFREBCn_MW_-WfR64v73E26_yu5BJ6B9RmI8qDFg5-Dy9_-3_LNWTHYw7DYoEWc5DjmA0Qsy8JAVKKqWfUb4E6cHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71456005</pqid></control><display><type>article</type><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SAGE Complete</source><source>Free Full-Text Journals in Chemistry</source><creator>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</creator><creatorcontrib>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</creatorcontrib><description>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</description><identifier>ISSN: 0022-1554</identifier><identifier>EISSN: 1551-5044</identifier><identifier>DOI: 10.1177/002215540205000308</identifier><identifier>PMID: 11850439</identifier><language>eng</language><publisher>Los Angeles, CA: Histochemical Soc</publisher><subject>Animals ; Biological Transport - drug effects ; Blotting, Western ; Cell Nucleus - metabolism ; Cytoplasm - metabolism ; DNA-Binding Proteins - analysis ; DNA-Binding Proteins - metabolism ; Enzyme Activation - drug effects ; Glucagon - analysis ; Immunohistochemistry ; Insulin - analysis ; Insulinoma ; Islets of Langerhans - chemistry ; Islets of Langerhans - metabolism ; Islets of Langerhans - ultrastructure ; Janus Kinase 2 ; Microscopy, Confocal ; Milk Proteins ; Pancreatic Neoplasms ; Phosphorylation ; Phosphotyrosine - metabolism ; Prolactin - pharmacology ; Protein-Tyrosine Kinases - metabolism ; Proto-Oncogene Proteins ; Rats ; Receptors, Prolactin - analysis ; Somatostatin - analysis ; STAT5 Transcription Factor ; Trans-Activators - analysis ; Trans-Activators - metabolism ; Tumor Cells, Cultured</subject><ispartof>The journal of histochemistry and cytochemistry, 2002-03, Vol.50 (3), p.365-383</ispartof><rights>2002 Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</citedby><cites>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/002215540205000308$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/002215540205000308$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11850439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brelje, T. Clark</creatorcontrib><creatorcontrib>Svensson, Annika M</creatorcontrib><creatorcontrib>Stout, Laurence E</creatorcontrib><creatorcontrib>Bhagroo, Nicholas V</creatorcontrib><creatorcontrib>Sorenson, Robert L</creatorcontrib><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><title>The journal of histochemistry and cytochemistry</title><addtitle>J Histochem Cytochem</addtitle><description>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</description><subject>Animals</subject><subject>Biological Transport - drug effects</subject><subject>Blotting, Western</subject><subject>Cell Nucleus - metabolism</subject><subject>Cytoplasm - metabolism</subject><subject>DNA-Binding Proteins - analysis</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Enzyme Activation - drug effects</subject><subject>Glucagon - analysis</subject><subject>Immunohistochemistry</subject><subject>Insulin - analysis</subject><subject>Insulinoma</subject><subject>Islets of Langerhans - chemistry</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - ultrastructure</subject><subject>Janus Kinase 2</subject><subject>Microscopy, Confocal</subject><subject>Milk Proteins</subject><subject>Pancreatic Neoplasms</subject><subject>Phosphorylation</subject><subject>Phosphotyrosine - metabolism</subject><subject>Prolactin - pharmacology</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins</subject><subject>Rats</subject><subject>Receptors, Prolactin - analysis</subject><subject>Somatostatin - analysis</subject><subject>STAT5 Transcription Factor</subject><subject>Trans-Activators - analysis</subject><subject>Trans-Activators - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0022-1554</issn><issn>1551-5044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM2O0zAUhS0EYjoDL8ACeQO70OvEjtNlNAKmUMRIlLXlOHbjUWIX2yGaN-CxcWklFkis7o--c67uQegVgXeEcL4GKEvCGIUSGABU0DxBq7wgBQNKn6LVCShOxBW6jvEBgFDKmufoipAmI9VmhX61Dm-naXZ-sDF5NejJKjni9ngMXqoBJ4-_eGeTDzgNGt8HP0qVrCus62ele9zm6adM1jvszR_mU_u5XH_bt3uG72UaFvmIrcutU0FnUOFtHHWKJ3wn3UGHQbr4Aj0zcoz65aXeoO8f3u9v74rd14_b23ZXKMo3qZBcQWcUcN41siFS0dqYjjFlqGl435VlpbUxzChV9pTphgPXVNUgVb3ZgKpu0Nuzb_7vx6xjEpONSo-jdNrPUXBCWQ3AMlieQRV8jEEbcQx2kuFREBCn_MW_-WfR64v73E26_yu5BJ6B9RmI8qDFg5-Dy9_-3_LNWTHYw7DYoEWc5DjmA0Qsy8JAVKKqWfUb4E6cHg</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>Brelje, T. Clark</creator><creator>Svensson, Annika M</creator><creator>Stout, Laurence E</creator><creator>Bhagroo, Nicholas V</creator><creator>Sorenson, Robert L</creator><general>Histochemical Soc</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020301</creationdate><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><author>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Biological Transport - drug effects</topic><topic>Blotting, Western</topic><topic>Cell Nucleus - metabolism</topic><topic>Cytoplasm - metabolism</topic><topic>DNA-Binding Proteins - analysis</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Enzyme Activation - drug effects</topic><topic>Glucagon - analysis</topic><topic>Immunohistochemistry</topic><topic>Insulin - analysis</topic><topic>Insulinoma</topic><topic>Islets of Langerhans - chemistry</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - ultrastructure</topic><topic>Janus Kinase 2</topic><topic>Microscopy, Confocal</topic><topic>Milk Proteins</topic><topic>Pancreatic Neoplasms</topic><topic>Phosphorylation</topic><topic>Phosphotyrosine - metabolism</topic><topic>Prolactin - pharmacology</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins</topic><topic>Rats</topic><topic>Receptors, Prolactin - analysis</topic><topic>Somatostatin - analysis</topic><topic>STAT5 Transcription Factor</topic><topic>Trans-Activators - analysis</topic><topic>Trans-Activators - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brelje, T. Clark</creatorcontrib><creatorcontrib>Svensson, Annika M</creatorcontrib><creatorcontrib>Stout, Laurence E</creatorcontrib><creatorcontrib>Bhagroo, Nicholas V</creatorcontrib><creatorcontrib>Sorenson, Robert L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of histochemistry and cytochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brelje, T. Clark</au><au>Svensson, Annika M</au><au>Stout, Laurence E</au><au>Bhagroo, Nicholas V</au><au>Sorenson, Robert L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</atitle><jtitle>The journal of histochemistry and cytochemistry</jtitle><addtitle>J Histochem Cytochem</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>50</volume><issue>3</issue><spage>365</spage><epage>383</epage><pages>365-383</pages><issn>0022-1554</issn><eissn>1551-5044</eissn><abstract>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</abstract><cop>Los Angeles, CA</cop><pub>Histochemical Soc</pub><pmid>11850439</pmid><doi>10.1177/002215540205000308</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1554
ispartof The journal of histochemistry and cytochemistry, 2002-03, Vol.50 (3), p.365-383
issn 0022-1554
1551-5044
language eng
recordid cdi_proquest_miscellaneous_71456005
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SAGE Complete; Free Full-Text Journals in Chemistry
subjects Animals
Biological Transport - drug effects
Blotting, Western
Cell Nucleus - metabolism
Cytoplasm - metabolism
DNA-Binding Proteins - analysis
DNA-Binding Proteins - metabolism
Enzyme Activation - drug effects
Glucagon - analysis
Immunohistochemistry
Insulin - analysis
Insulinoma
Islets of Langerhans - chemistry
Islets of Langerhans - metabolism
Islets of Langerhans - ultrastructure
Janus Kinase 2
Microscopy, Confocal
Milk Proteins
Pancreatic Neoplasms
Phosphorylation
Phosphotyrosine - metabolism
Prolactin - pharmacology
Protein-Tyrosine Kinases - metabolism
Proto-Oncogene Proteins
Rats
Receptors, Prolactin - analysis
Somatostatin - analysis
STAT5 Transcription Factor
Trans-Activators - analysis
Trans-Activators - metabolism
Tumor Cells, Cultured
title An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A45%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Immunohistochemical%20Approach%20to%20Monitor%20the%20Prolactin-induced%20Activation%20of%20the%20JAK2/STAT5%20Pathway%20in%20Pancreatic%20Islets%20of%20Langerhans&rft.jtitle=The%20journal%20of%20histochemistry%20and%20cytochemistry&rft.au=Brelje,%20T.%20Clark&rft.date=2002-03-01&rft.volume=50&rft.issue=3&rft.spage=365&rft.epage=383&rft.pages=365-383&rft.issn=0022-1554&rft.eissn=1551-5044&rft_id=info:doi/10.1177/002215540205000308&rft_dat=%3Cproquest_cross%3E71456005%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71456005&rft_id=info:pmid/11850439&rft_sage_id=10.1177_002215540205000308&rfr_iscdi=true